Multiple Sclerosis: A Review of Pathophysiology, Current Treatments, and Potential Therapeutic Agents

Publications Category :

Author(s): Valeria Montalvo, Raj Jha

Project Description : Over the past several years, the use of disease modifying therapies to target the pathophysiology of MS has greatly improved. There are now over twenty DMTs that are available for MS patients. These include interferons, glatiramer acetate, sphingosine-1-phosphate receptor modulators, fumarates, etc.

Additional Informational : Presented at the Kansas Association of Osteopathic Medicine (KAOM) Mid-Year CME Conference, KansasCOM, Wichita, KS, Nov 1-2, 2024

Media: MS: A Review of Pathophysiology, Current Treatments, and Potential Therapeutic Agents

© 2025 Kansas Health Science University. All Rights Reserved.
Accessibility Mode: Off
Accessibility Statement

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .